MedPath

The effect of laser therapy on gingival inflammatio

Not Applicable
Conditions
Gingival inflammation.
Gingivitis and periodontal diseases
Registration Number
IRCT2017011620523N2
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Signing informed consent; Absence of active periodontal disease (probing depth less than 4 mm and lack of bleeding on probing in upper first molars); Absence of systemic disease.
Exclusion criteria: Presence of coagulation disease; Presence of acute or chronic disease (Based on patient chart); Presence of auto-immune disease; Patients under immune-suppressive therapy or radiotherapy; Patients who consume antibiotics; Patients who consume corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDS); Pregnant women.
8. Patients under periodontal treatment or prolonged consumption of chlorhexidine

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of interleukin 1 beta in gingival crevicular fluid. Timepoint: Before placement of separator and 1 week later. Method of measurement: ELISA on gingival crevicular fluid.
Secondary Outcome Measures
NameTimeMethod
Bleeding point index. Timepoint: Before placement of separator and 1 week later. Method of measurement: Occurence of bleeding during the movement of periodontal probe in gingival sulcus.;Gingival index. Timepoint: Before placement of separator and 1 week later. Method of measurement: Observation.
© Copyright 2025. All Rights Reserved by MedPath